Like most healthcare markets, the diagnostic cardiology market has had a bumpy ride in recent years. The COVID-19 pandemic saw global revenues for Resting ECG devices increase in 2020, whilst ECG Management Systems, Stress ECG and Traditional Holter ECG solutions saw a market decline. Country lockdowns resulted in reduced cardiology services during the peak of the pandemic, as non-urgent appointments were delayed. 2021 showed relief for cardiac facilities as providers started to deal with the
Read More
Cardiac Insight
Ultromics Raises $33M for AI-Enabled Echocardiograms to Help Clinicians Diagnose Heart Disease
What You Should Know:
- Today, Ultromics, an Oxford, England-based health-tech startup announced it has raised $33M in Series B funding led by Blue Ventures, the investing arm of Blue Cross Blue Shield, and also includes investment from Optum Ventures, GV, and Oxford Sciences.
- Born at the University of Oxford and built-in partnership with the U.K.’s NHS, Ultromics has developed the first fully automated solution for echocardiography and analysis of global longitudinal strain (GLS).
Read More
Cardiac Insight Lands $2.5M for Portable, Hand-held ECG Device
Cardiac Insight, a University of Washington spinoff focused on developing advanced body-worn sensing for diagnostic testing in cardiology has raised $2.5 million in Series C funding. The company will utilize the funding to accelerate the market penetration of it's CardeaScreen™ product as well as finalize the development of the company’s proprietary wearable sensor technology.Cardea’s flagship product is the CardeaScreen, is a 12-lead electrocardiogram (ECG) exam that helps identify young
Read More
